Cargando…

WNT5A Inhibits Metastasis and Alters Splicing of Cd44 in Breast Cancer Cells

Wnt5a is a non-canonical signaling Wnt. Low expression of WNT5A is correlated with poor prognosis in breast cancer patients. The highly invasive breast cancer cell lines, MDA-MB-231 and 4T1, express very low levels of WNT5A. To determine if enhanced expression of WNT5A would affect metastatic behavi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Wen, Crossman, David K., Mitchell, Elizabeth H., Sohn, Philip, Crowley, Michael R., Serra, Rosa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590134/ https://www.ncbi.nlm.nih.gov/pubmed/23484019 http://dx.doi.org/10.1371/journal.pone.0058329

Ejemplares similares

Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer
por: Inoue, Kazushi, et al.
Publicado: (2015)

CD44 increases the efficiency of distant metastasis of breast cancer
por: McFarlane, Suzanne, et al.
Publicado: (2015)

CD44V3, an Alternatively Spliced Form of CD44, Promotes Pancreatic Cancer Progression
por: Zhu, Hanzhang, et al.
Publicado: (2022)

CD44 splice isoform switching determines breast cancer stem cell state
por: Zhang, Honghong, et al.
Publicado: (2019)

Long noncoding RNA LINC01594 inhibits the CELF6-mediated splicing of oncogenic CD44 variants to promote colorectal cancer metastasis
por: Liu, Bowen, et al.
Publicado: (2023)

CD44 regulates Wnt signaling at the level of LRP6
por: Orian-Rousseau, Véronique, et al.
Publicado: (2015)

CD82 suppresses CD44 alternative splicing-dependent melanoma metastasis by mediating U2AF2 ubiquitination and degradation
por: Zhang, Pu, et al.
Publicado: (2016)

Association of human breast cancer CD44(-)/CD24(-) cells with delayed distant metastasis
por: Qiao, Xinbo, et al.
Publicado: (2021)

Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons
Publicado: (1995)

The emerging role of CD44 in regulating skeletal metastasis
por: Hill, A, et al.
Publicado: (2006)

CD44: A metastasis driver and therapeutic target
por: Sottnik, Joseph L., et al.
Publicado: (2016)

TDP43 promotes stemness of breast cancer stem cells through CD44 variant splicing isoforms
por: Guo, Lu, et al.
Publicado: (2022)

Relationship of CD44(+)CD24(-/low) breast cancer stem cells and axillary lymph node metastasis
por: Wei, Wei, et al.
Publicado: (2012)

Downregulation of CD44 reduces doxorubicin resistance of CD44(+)CD24(−) breast cancer cells
por: Van Phuc, Pham, et al.
Publicado: (2011)

Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer.
por: Sliutz, G., et al.
Publicado: (1995)

Identification of CD44 splice variant in Korean colorectal cancers and cell lines.
por: Suh, S. I., et al.
Publicado: (1995)

Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion
por: Gaiteiro, Cristiana, et al.
Publicado: (2022)

The p53-induced RNA-binding protein ZMAT3 is a splicing regulator that inhibits the splicing of oncogenic CD44 variants in colorectal carcinoma
por: Muys, Bruna R., et al.
Publicado: (2021)

Deletion of Cd44 Inhibits Metastasis Formation of Liver Cancer in Nf2-Mutant Mice
por: Gerardo-Ramírez, Monserrat, et al.
Publicado: (2023)

CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis
por: Loreth, Desiree, et al.
Publicado: (2021)

SALL4 ‐ KHDRBS3 network enhances stemness by modulating CD44 splicing in basal‐like breast cancer
por: Matsumoto, Yoshiaki, et al.
Publicado: (2018)

Prevention of tumor metastasis formation by anti-variant CD44
Publicado: (1993)

Role of Versican, Hyaluronan and CD44 in Ovarian Cancer Metastasis
por: Ween, Miranda P., et al.
Publicado: (2011)

CD44(+)/CD24(- )breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis
por: Sheridan, Carol, et al.
Publicado: (2006)

Molecular genetic characterization of alternatively spliced CD44 transcripts in human stomach carcinoma.
por: Kim, Y. S., et al.
Publicado: (1997)

Characteristics of CD44 alternative splice pattern in the course of human colorectal adenocarcinoma progression
por: Bánky, Balázs, et al.
Publicado: (2012)

Commentary: HNRNPLL, a newly identified colorectal cancer metastasis suppressor, modulates alternative splicing of CD44 during epithelial-mesenchymal transition
por: Baranwal, Somesh
Publicado: (2017)

Rb Suppresses Collective Invasion, Circulation and Metastasis of Breast Cancer Cells in CD44-Dependent Manner
por: Kim, Kui-Jin, et al.
Publicado: (2013)

CD44 Promotes Breast Cancer Metastasis through AKT-Mediated Downregulation of Nuclear FOXA2
por: Vadhan, Anupama, et al.
Publicado: (2022)

Loss of TGF-β or Wnt5a results in an increase in Wnt/β-catenin activity and redirects mammary tumour phenotype
por: Roarty, Kevin, et al.
Publicado: (2009)

CD44 activation state regulated by the CD44v10 isoform determines breast cancer proliferation
por: Guo, Qian, et al.
Publicado: (2021)

Functional Genomic mRNA Profiling of Colorectal Adenomas: Identification and in vivo Validation of CD44 and Splice Variant CD44v6 as Molecular Imaging Targets
por: Hartmans, Elmire, et al.
Publicado: (2017)

Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer.
por: Gotley, D. C., et al.
Publicado: (1996)

Alternative CD44 splicing identifies epithelial prostate cancer cells from the mesenchymal counterparts
por: Hernandez, James R., et al.
Publicado: (2015)

SR proteins regulate V(6) exon splicing of CD44 pre-mRNA
por: Loh, Tiing Jen, et al.
Publicado: (2016)

hnRNPK promotes gastric tumorigenesis through regulating CD44E alternative splicing
por: Peng, Wei-zhao, et al.
Publicado: (2019)

CD44 targets Wnt/β-catenin pathway to mediate the proliferation of K562 cells
por: Chang, Guoqiang, et al.
Publicado: (2013)

Wnt signaling is boosted during intestinal regeneration by a CD44-positive feedback loop
por: Walter, Romina J., et al.
Publicado: (2022)

miR-302a Inhibits Metastasis and Cetuximab Resistance in Colorectal Cancer by Targeting NFIB and CD44
por: Sun, Lina, et al.
Publicado: (2019)

Overexpression of CBS/H(2)S inhibits proliferation and metastasis of colon cancer cells through downregulation of CD44
por: Zhang, Yuyang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v3d78c7binunk4lu9o5tqn62ae